Midwest Biomedical Research Foundation   Report issue

Foundation Phase 2
Founded: Kansas City MO United States (1989)

Organization Overview

First Clinical Trial
2005
NCT00614757
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cocaine-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 6